de Technologies Chimiques et Biologiques

pour la Santé

Accueil du site > Research Teams > Team "Immunology": Cytokine modulation of Hematopoiesis > Articles


Date of publication: 4 December 2017


Team "Immunology" : Cytokine modulation of Hematopoiesis

Team Home page
Research Themes

Recent articles

2017 | 2016 | 2015

2017 articles:

- Hacein-Bey-Abina S., Echchakir H., Estienne M., Pederzoli-Ribeil M., Bessoles S…..Abina A. Mpl-EpoR competition during megakaryopoiesis regulates platelet production and activation. Submitted

- Auer F., Ingenhag D., Pinkert S., Kracker S., Hacein-Bey-Abina S., Cavazzana M., Gombert M., Martín-Lorenzo A., Lin M., Vicente-Dueñas C., Sánchez-García I., Borkhardt A., and Hauer J. Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells. In press, Oncotarget J. IF 2016: 5,17.

- Martin K.R., Pederzoli-Ribeil M., et al. Transgenic mice expressing human proteinase 3 exhibit sustained neutrophil-associated peritonitis. In press, J Immunol. IF 2016: 5,22.

- Ribeil J.A*., Hacein-Bey-Abina S*., Payen E., Magnani A., Semeraro M., Magrin E., Caccavelli L., Neven B., Bourget P., El Nemer W., Bartolucci P., Weber L., Puy H., Meritet J.F., Grevent D., Beuzard Y., Chrétien S., Lefebvre T., Ross R.W., Negre O., Veres G., Sandler L., Soni S., de Montalembert M., Blanche S., Leboulch P., Cavazzana M. Gene therapy in a patient with sickle cell disease. N Engl J Med. 2017; 376(9):848-855. Co-First authors; IF 2016 : 72,406.


2016 articles:

- Sherman E., Nobles C., Berry C.C., Six E., Wu Y., Dryga A., Malani N., Male F., Reddy S., Bailey A., Bittinger K., Everett J.K., Caccavelli L., Drake M.J., Bates P., Hacein-Bey-Abina S., Cavazzana M., Bushman FD. INSPIIRED : A pipeline for quantitative analysis of sites of new DNA integration in cellular genomes. Mol. Ther. Methods. Clin. Dev. 2016, 4, 39-49. IF 2016: 2,61.

- Berry C.C., Nobles C., Six E., Wu Y., Malani N., Sherman E., Dryga A., Everett J.K., Male F., Bailey A., Bittinger K., Drake M.J., Caccavelli L., Bates P., Hacein-Bey-Abina S., Cavazzana M., Bushman F.D. INSPIIRED : Quantification and visualization tools fro analyzing integration site distributions. Mol. Ther. Methods. Clin. Dev. 2016, 4, 17-26. IF 2016: 2,61.

- Martin K.R., Kantari-Mimoun C., Yin M., Pederzoli-Ribeil M., Angelot-Delettre F., Ceroi A., Grauffel C., Benhamou M., Reuter N., Saas P., Frachet P., Boulanger C.M., Witko-Sarsat V. Proteinase 3 is a phophatidylserine-binding protein that affects the production and function of microvesicles. J Biol Chem. 2016, 291(20):10476-89. IF 2016: 4,125.

- Martin C., Ohayon D., Alkan M., Mocek J., Pederzoli-Ribeil M., Candalh C., Thevenot G., Millet A., Tamassia N., Cassatella M.A., Thieblemont N., Burgel P.R., Witko-Sarsat V. Neutrophil-expressed p21/waf1 favors inflammation resolution in Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 2016, 54(5):740-50. IF 2016: 4,100.

- Creidy R., Moshous D., Touzot F., Elie C., Neven B., Gabrion A., Leruez-Ville M., Maury S., Ternaux B., Nisoy J., Luby J.M., Héritier S., Dalle J.H., Ouachée-Chardin M., Xhaard A., Thomas X., Chevallier P., Souchet L., Treluyer J.M., Picard C., Hacein-Bey-Abina S., Dal Cortivo L., Blanche S., Cavazzana M. Specific T cells for the treatment of CMV and/or adenovirus in the context of hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2016, 138 (3), 920-924. IF 2016: 13,081.

- Negre O., Eggimann A.V., Beuzard Y., Ribeil J.A., Bourget P., Borwornpinyo S., Hongeng S., Hacein-Bey S., Cavazzana M., Leboulch P., Payen E. Gene therapy of -hemoglobinopathies by lentiviral transfer of the (A(T87Q))-globin gene. Hum Gene Ther. 2016, 27(2):148-65. IF 2016: 4,187.

- Ludigs K., Jandus C., Utzschneider D.T., Staehli F., Bessoles S., Dang A.T., Rota G., Castro W., Zehn D., Vivier E., Held W., Romero P., Guarda G. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016, 7:10554. IF 2016: 12,124.


2015 articles:

- Hacein-Bey Abina S., Gaspar H.B., Blondeau J., Caccavelli L., Charrier S., Buckland K., Picard C., Six E., Himoudi N., Gilmour K., McNicol A.M., Hara H., Xu-Bayford J., Rivat C., Touzot F., Mavilio F., Lim A., Treluyer J.M., Héritier S., Lefrère F., Magalon J., Pengue-Koyi I., Honnet G., Blanche S., Sherman E.A., Male F., Berry C., Malani N., Bushman F.D., Fischer A., Thrasher A.J., Galy A., Cavazzana M. Outcomes following gee therapy in patients with severe Wiskott-Aldrich syndrome. JAMA. 2015, 313(15):1550-63. IF 2016: 44,405.

- Touzot F., Moshous D., Creidy R., Neven B., Frange P., Cros G., Caccavelli L., Blondeau J., Magnani A., Luby J.M., Ternaux B., Picard C., Blanche S., Fischer A., Hacein-Bey-Abina S.*, Cavazzana M*. Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1. Blood. 2015,125(23):3563-9. IF 2016: 13,164. . *Co-last senior author

- Soudais C., Samassa F., Sarkis M., Le Bourhis L., Bessoles S., Blanot D., Hervé M., Schmidt F., Mengin-Lecreulx D., Lantz O. In vitro and in vivo analysis of Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J Immunol. 2015, 194(10):4641-9. IF 2016: 4,856.

- Magalhaes I., Pingris K., Poitou C., Bessoles S., Venteclef N., Kiaf B., Beaudoin L., Da Silva J., Allatif O., Rossjohn J., Kjer-Nielsen L., McCluskey J., Ledoux S., Genser L., Torcivia A., Soudais C., Lantz O., Boitard C., Aron-Wisnewsky J., Larger E., Clément K., Lehuen A. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest. 2015, 125(4):1752-62. IF 2016 : 12,784.

- Navarro J.M., Touzart A., Pradel L.C., Loosveld M., Koubi M., Fenouil R., Le Noir S., Maqbool M.A., Morgado E., Gregoire C., Jaeger S., Mamessier E., Pignon C., Hacein-Bey-Abina S., Malissen B., Gut M., Gut I.G., Dombret H., Macintyre E.A., Howe S.J., Gaspar H.B., Thrasher A.J., Ifrah N., Payet-Bornet D., Duprez E., Andrau J.C., Asnafi V., Nadel B. Site- and allele-specific polycomb dysregulation in T-cell leukaemia. Nat Commun. 2015, 6:6094. IF 2016: 12,124.